The EMA has posted the press release with details of the CVMP's meeting of 2 – 4 June 2015 (Link). General news relating to regulatory affairs includes:
- The Committee adopted a concept paper on the testing strategy and risk assessment for plants in Phase II of the environmental risk assessment for veterinary medicinal products for a 3-month period of public consultation.
- The Committee adopted the latest combined VeDDRA list of clinical terms for reporting suspected adverse reactions to veterinary medicinal products, following the yearly review and update.
- The Committee adopted a reflection paper on the use of cocrystals of active substances in medicinal products and overview of comments following the close of the public consultation.